Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

It's par for the course if the IRB and Safety Committee see some benefit to patients for continuing. The benefit can range from "the drug does no harm so why not?" to "hmm, we think it might have done something and it looks safe." I doubt we will know the answer to that, though the first and lowest bar was cleared. No, not all oncology drugs clear that lowest bar.